LPL Financial
RPRX icon

LPL Financial’s Royalty Pharma RPRX Stock Holding History

LPL Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.5M Sell
214,592
-34,525
-14% -$2.04M ﹤0.01% 1999
2026
Q2 		$14M Buy
249,117
+51,186
+26% +$2.66M ﹤0.01% 1842
2026
Q1 		$9.49M Buy
197,931
+83,050
+72% +$3.64M ﹤0.01% 2042
2025
Q4 		$4.44M Buy
114,881
+7,256
+7% +$277K ﹤0.01% 2631
2025
Q3 		$3.8M Buy
107,625
+54,650
+103% +$1.98M ﹤0.01% 2726
2025
Q2 		$1.91M Sell
52,975
-16,166
-23% -$536K ﹤0.01% 3170
2025
Q1 		$2.15M Buy
69,141
+45,236
+189% +$1.43M ﹤0.01% 2893
2024
Q4 		$610K Sell
23,905
-2,859
-11% -$75.8K ﹤0.01% 3917
2024
Q3 		$757K Sell
26,764
-18,294
-41% -$507K ﹤0.01% 3653
2024
Q2 		$1.19M Buy
45,058
+16,207
+56% +$449K ﹤0.01% 3093
2024
Q1 		$876K Buy
28,851
+8,327
+41% +$245K ﹤0.01% 3307
2023
Q4 		$577K Buy
20,524
+5,241
+34% +$144K ﹤0.01% 3555
2023
Q3 		$415K Sell
15,283
-3,555
-19% -$106K ﹤0.01% 3633
2023
Q2 		$579K Buy
18,838
+296
+2% +$10K ﹤0.01% 3316
2023
Q1 		$668K Buy
18,542
+10,984
+145% +$407K ﹤0.01% 3109
2022
Q4 		$299K Sell
7,558
-2,337
-24% -$97.5K ﹤0.01% 3651
2022
Q3 		$398K Buy
9,895
+763
+8% +$32.6K ﹤0.01% 3353
2022
Q2 		$384K Buy
9,132
+2,201
+32% +$90.2K ﹤0.01% 3430
2022
Q1 		$270K Sell
6,931
-789
-10% -$31K ﹤0.01% 3643
2021
Q4 		$308K Buy
+7,720
New +$300K ﹤0.01% 3664
2021
Q1 		– Sell
-5,694
Closed -$285K – 4137
2020
Q4 		$285K Sell
5,694
-14,056
-71% -$596K ﹤0.01% 3243
2020
Q3 		$831K Buy
19,750
+10,867
+122% +$466K ﹤0.01% 2089
2020
Q2 		$431K Buy
+8,883
New +$440K ﹤0.01% 2527

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

LPL Financial's RPRX Position: Q3 2026 in Review

LPL Financial reduced its Royalty Pharma (RPRX) stake by 14% in Q3 2026, selling an estimated $2.04M and leaving 214,592 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

LPL Financial first reported a position in RPRX in Q2 2020 and has held it in 23 quarters since. The position peaked at $14M in Q2 2026. 318 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • LPL Financial held 214,592 shares of Royalty Pharma worth $12.5M as of Q3 2026.
  • LPL Financial sold 34,525 Royalty Pharma shares in Q3 2026, an estimated $2.04M.
  • Royalty Pharma made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #1999 holding.
  • LPL Financial first reported a position in Royalty Pharma in Q2 2020 and has held it in 23 quarters since.
  • LPL Financial's Royalty Pharma position peaked at $14M in Q2 2026.
  • 318 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.